Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
19.12
-0.38 (-1.95%)
Oct 10, 2025, 4:00 PM EDT - Market closed
Seres Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Cash & Equivalents | 45.38 | 30.79 | 127.97 | 163.03 | 180 | 116.05 | Upgrade |
Short-Term Investments | - | - | - | 18.31 | 110.7 | 137.57 | Upgrade |
Cash & Short-Term Investments | 45.38 | 30.79 | 127.97 | 181.34 | 290.71 | 253.62 | Upgrade |
Cash Growth | -36.29% | -75.94% | -29.43% | -37.62% | 14.62% | 167.48% | Upgrade |
Other Receivables | 0.88 | 2.07 | - | - | - | 9.39 | Upgrade |
Total Trade Receivables | 0.88 | 2.07 | - | - | - | 9.39 | Upgrade |
Other Current Assets | 2.42 | 5.81 | 47.45 | 13.42 | 12.92 | 5.77 | Upgrade |
Total Current Assets | 48.69 | 38.67 | 175.41 | 194.76 | 303.63 | 268.78 | Upgrade |
Net Property, Plant & Equipment | 86.42 | 92.44 | 108.03 | 133.97 | 36.15 | 22.94 | Upgrade |
Long-Term Investments | - | - | 1.4 | 1.4 | 1.9 | 51.23 | Upgrade |
Other Long-Term Assets | 8.7 | 8.7 | 73.76 | 18.65 | 13.19 | - | Upgrade |
Total Assets | 143.8 | 139.81 | 358.6 | 348.78 | 354.86 | 342.94 | Upgrade |
Accounts Payable | 2.2 | 4.08 | 3.64 | 17.44 | 13.74 | 4.02 | Upgrade |
Accrued Expenses | 19.26 | 28.47 | 22.51 | 59.84 | 45.09 | 14.23 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 0.46 | - | 0.45 | Upgrade |
Current Portion of Leases | 9.48 | 8.67 | 5.59 | 3.6 | 6.61 | 5.12 | Upgrade |
Unearned Revenue | - | - | - | 4.26 | 16.82 | 22.6 | Upgrade |
Other Current Liabilities | - | - | 66.92 | - | - | - | Upgrade |
Total Current Liabilities | 30.94 | 41.22 | 98.66 | 85.6 | 82.26 | 46.42 | Upgrade |
Long-Term Debt | - | - | 101.54 | 50.59 | 24.64 | 24.64 | Upgrade |
Long-Term Leases | 77.96 | 82.97 | 91.65 | 107.94 | 17.96 | 10.56 | Upgrade |
Other Long-Term Liabilities | 1.95 | 1.84 | 111.6 | 93.87 | 98.49 | 86.58 | Upgrade |
Total Long-Term Liabilities | 79.91 | 84.8 | 304.8 | 252.41 | 141.09 | 121.78 | Upgrade |
Total Liabilities | 110.85 | 126.03 | 403.46 | 338 | 223.35 | 168.19 | Upgrade |
Common Stock | 0.01 | 0.01 | 0.14 | 0.13 | 0.09 | 0.09 | Upgrade |
Additional Paid-in Capital | 998.21 | 991.87 | 933.24 | 875.18 | 745.83 | 723.48 | Upgrade |
Accumulated Other Comprehensive Income | - | - | - | -0.01 | -0.06 | -0.05 | Upgrade |
Retained Earnings | -965.27 | -978.1 | -978.24 | -864.51 | -614.35 | -548.78 | Upgrade |
Shareholders' Equity | 32.95 | 13.78 | -44.86 | 10.78 | 131.51 | 174.75 | Upgrade |
Total Liabilities & Equity | 143.8 | 139.81 | 358.6 | 348.78 | 354.86 | 342.94 | Upgrade |
Total Debt | 87.43 | 91.64 | 198.78 | 162.59 | 49.21 | 40.77 | Upgrade |
Net Cash (Debt) | -42.06 | -60.85 | -70.82 | 18.75 | 241.5 | 212.85 | Upgrade |
Net Cash Growth | - | - | - | -92.23% | 13.46% | 325.39% | Upgrade |
Net Cash Per Share | -5.00 | -7.83 | -11.06 | 3.47 | 52.67 | 53.35 | Upgrade |
Book Value | 32.95 | 13.78 | -44.86 | 10.78 | 131.51 | 174.75 | Upgrade |
Book Value Per Share | 3.92 | 1.77 | -7.01 | 2.00 | 28.68 | 43.80 | Upgrade |
Tangible Book Value | 32.95 | 13.78 | -44.86 | 10.78 | 131.51 | 174.75 | Upgrade |
Tangible Book Value Per Share | 3.92 | 1.77 | -7.01 | 2.00 | 28.68 | 43.80 | Upgrade |
Updated Aug 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.